Scinovex
review Open AccessTop 1% cited

The links between gut microbiota and obesity and obesity related diseases

Biomedicine & Pharmacotherapy · 2022 · Vol. 147 · pp. 112678–112678
Jiafeng GengQingqiang NiWei SunLiangge LiXiujing Feng

Abstract

The obesity epidemic has become a global public health crisis in recent years and is continuing to worsen at an alarming rate. However, the pathophysiological mechanisms involved in the development of obesity and obesity-related diseases are still being unraveled. In the past ten years, the gut microbiota has been identified as a crucial player affecting the onset and progression of obesity and obesity-related diseases, especially with respect to changes in its composition and metabolites during obesity progression. Herein, we summarize the roles and mechanisms of gut microbiota's composition and metabolite changes in the gut play in obesity and obesity related diseases. Furthermore, we discuss potential therapeutic treatments that can be used to modulate the gut microbiome composition and target the relevant metabolic pathways of obesity and obesity-related metabolic diseases.

Gut microbiota and healthDiet and metabolism studiesDiet, Metabolism, and DiseaseObesityGut floraMicrobiomeGut microbiomeManagement of obesityMedicineBiologyBioinformaticsImmunologyInternal medicine

MeSH terms

Gastrointestinal MicrobiomeDietFatty Acids, VolatileHumansIndolesObesityPolyaminesDown-RegulationUp-RegulationProbioticsPrebioticsDysbiosis
Citations
358
FWCI
28.51
field-weighted impact
References
183
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.